Document pmrnKBErdQkVaNQ5Q2Vgo2vpw
For Distribution, See Page 2
E. 1. d u Po n t d e Ne mo u r s a n d Co mp a n y
Haskell Laboratory for Toxicology
and Industrial Medicine
P.O. Box 50, Elkton Road
Newark, Delaware 19714
May 24, 1991
DU PONT CENTRAL RESEARCH AND DEVELOPMENT
CONFIDENTIAL
To: K. D. Dastur Chemicals B-17249-5
From:
C. F. Reinhardt, M.D.
CR&D Hashell Laboratory
^
R. N. Ligo, M.D.
Human Resources N-11400
tfl/Ls'
:
/
LEAD AND LEAD COMPOUNDS ADDENDUM TO HAZARD DETERMINATION LETTER DATED JULY 10, 1989
Lead and lead compounds were reviewed July 10, 1989 according to the corporate guidelines for control of carcinogenic, reproductive, and developmental risks posed by chemicals made or used within Du Pont-
That review concluded that lead and its compounds should be handled as reproductive and developmental hazards which represented a continuation of the practice already in place. However, the recommendation was made for women of childbearing capability to avoid exposures to lead above background as measured by blood lead. In the United States, blood lead levels average about 10 ug/dL.
The recent Supreme Court decision in the Johnson controls case prohibits all fetal protection policies that preclude women from obtaining certain jobs.
Therefore, as a guide to protect the fetus, women of child bearing capability who might elect to work with lead or its compounds should be advised to avoid adding lead to their normal body burden as measured by blood lead levels. In other words, when background levels, as reflected by blood lead measurements for that geographic area, are significantly exceeded, the women should be advised to consider other assignments that would not expose them to lead.
DUP040011327
Copies to;
W. P. Anderson B. A. Beach N. Bell A. S. Berg M, W, Brockman M. M. Coburn j. E. Cole J, r . cooper K. D. Dastur M, S. Deak J, R. Baden
G. E. Harper T. Hendrick III G. J. Hollod
D. W. Johnson B. W. Karrh, M.D. j. s. Kelley J. E. Leemann C. J. Markovchik j. f . Matheson W. J. Mottel G. J. Patterson V. R. Rice G. P. Robson R. A. Romanel1i S, C. Saltzman B- K. Saydlowski A. H. Schultz C. S. Seringer J. M, Wesley
polymers Consol Chemicals HR Fibers AP CR&D HR Chemicals Polymers
AG ML&S
AP Chemicals
Conoco HR EA chemicals
ML&S Conoco HR
AP LEGL DuP/Canada Chemicals ML&S E/ IMG Chemicals Chemicals ENGG
E. VL. De Whitt, Jr. S. W. Dixon W C. Haaf M. J. Hofmann A. MacLachlan F. P. Mulherln T. J. Nelson J. C, Olguin p, c. olguin R. D. Richardson M. E. Sabla L. C. Schaller
HR HR HR CR&D ADMN HR HR HR HR HR HR HR
J. G. Aftosmis J, R. Gibson A. M. Kaplan N. D, Krivanek H. J. Trochimowicz
CR&D CR&D CR&D CR&D
CR&D
D-12026-2
Pittsburgh B-12252A N-11458 CRP MR-2015 B--3.324-5 E-326/301 N-11539 B-17249-5 0-12016 WM 6-252 CRP-700 B--1218 CRP HR-2092 Houston D-2042 M-7722A B--16271
CRP-700 Houston N-11543
B-5222 D-7016-2 Kingston, Ontario, BOD 918-8 D-2086-2 BMP 21-1152 B-14236 B-13256 L-2316
Canada
s
N-11498-3 N-11502 N-11530 E-326/208
D-9152 N-11500
N-11503-2 N-11498-1 CRP-718-4 N-11502-2
BMP 14-2170 N-11466
Haskell Laboratory Haskell Laboratory Haskell Laboratory Haskell Laboratory Haskell Laboratory
2- -
DUP040011328
Copies (Cont'd)
International
Koichi Fujiwara M. Fornasari G. Grulich G. Heins E. W. Leppin G. Minionis L. Murphy E. Salazar I. A. P. Scott J. C, Siqueira J. M. Taylor D. Wika
DuP/Japan
Tokyo, Japan
DuP/Argentina Buenos Aires, Argentina
DuP/Taiwan Taipei, Taiwan
DuP/Columbia Bogota, Columbia
DuP/Germany Bad Homburg, Germany
DuP/Venezuela Caracas, Venezuela
DuP/Australia North Sydney, Australia
DuP/Mexico Damian, Mexico City
DISA
Geneva, Switzerland
DuP/Brazil
Sao Paulo, Brazil
DuP/Canada
Kingston, Ontario
DuP/Far East Singapore
CFR:RNL:rcg May 24, 1991 HAZ6.11
-3
DUP040011329